Learning objectives
After watching this webinar, participants will be aware:
Needs assessment and expected educational outcome
To be aware of the latest treatment options for HCM, including new drugs as well as non-pharmacological therapies.
This programme is supported by Bristol Myers Squibb in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic
Related topic
This webinar is designed for Nurses & allied professionals working in cardiology andhealthcare professionals with an interest in hypertrophic cardiomyopathy
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).